Article Information
PubMed
Published By
History
- Received January 25, 2024
- Revision received August 8, 2024
- Accepted November 4, 2024
- Published online July 23, 2025.
Article Versions
- Previous version (November 28, 2024 - 04:26).
- Previous version (May 7, 2025 - 02:52).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2025, The Authors This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)
Author Information
- Ann Hutchinson1,*,
- Richard Russell2,
- Helena Cummings3,
- Omar Usmani4,
- Sarah MacFadyen5,
- Judith Cohen6,
- Tamsin Morris7,
- Hana Muellerova8,
- Yang Xu7,
- Gary Hellens7,
- Kay Roy9 and
- Michael G Crooks1
- 1 Hull York Medical School, University of Hull, Hull, UK
- 2 Peter Gorer Deptartment of Immunobiology, King’s College London, London, UK
- 3 Hull University Teaching Hospitals NHS Trust, Hull, UK
- 4 Imperial College London, London, UK
- 5 Asthma and Lung UK, London, UK
- 6 Hull Health Trials Unit, University of Hull, Hull, UK
- 7 AstraZeneca UK, London, UK
- 8 AstraZeneca BioPharmaceuticals Medical, Cambridge, UK
- 9 University College London Hospitals NHS Foundation Trust, London, UK
- ↵
*For correspondence:
Ann Hutchinson, ann.hutchinson{at}hyms.ac.uk
Article usage
Statistics from Altmetric.com
In this issue
Exploring patients’ and carers’ experiences, understandings and expectations of COPD exacerbations:an interview study
Jump to section
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals
